Skip to content
Inciteful Med
Resources About us Ask a Question

What is the Difference: IgG4-RD vs Sjögren's Syndrome?

Published: | Updated:

IgG4-Related Disease and Sjögren's Syndrome are distinct immune disorders that affect salivary and tear glands. Sjögren's causes severe dryness, while IgG4-RD causes firm gland swelling. Because they require very different treatments, blood tests and tissue biopsies are crucial for a diagnosis.

Key Takeaways

  • • IgG4-Related Disease is a clinical mimic of Sjögren's syndrome that can cause identical-looking swelling in the face and neck.
  • • Sjögren's syndrome typically presents with severe dry eyes and dry mouth, while IgG4-RD primarily causes chronic, firm glandular swelling.
  • • Blood tests for Anti-SSA/SSB antibodies typically point to Sjögren's, whereas elevated serum IgG4 levels suggest IgG4-Related Disease.
  • • A tissue biopsy is the gold standard for confirming the diagnosis by revealing distinct cellular patterns and specific types of scarring.
  • • Getting an accurate diagnosis is critical because IgG4-RD responds rapidly to steroids, while Sjögren's treatment focuses on symptom management.

No, IgG4-Related Disease (IgG4-RD) is not the same thing as Primary Sjögren’s Syndrome, even though they can cause identical-looking swelling in the face and neck [1]. IgG4-RD is a major “clinical mimic” of Sjögren’s [2]. Both are immune system disorders that target the salivary and tear glands, but they do so in completely different ways [1]. While Sjögren’s gradually damages the glands and causes severe dryness, IgG4-RD aggressively inflames the glands, causing them to enlarge without always stopping their ability to produce moisture [3]. Differentiating between the two requires specific blood work and tissue biopsies, which is critical because they are treated using entirely different approaches [4].

How the Symptoms Differ

While both conditions affect the salivary glands (glands that make saliva) and lacrimal glands (glands that make tears), the way you experience them often varies [3].

  • Sjögren’s Syndrome: The hallmark of Sjögren’s is profound xerostomia (severe dry mouth) and keratoconjunctivitis sicca (severe dry eyes) [3]. This happens because the immune system gradually damages and impairs the moisture-producing tissues over time. Glandular swelling in Sjögren’s can sometimes fluctuate, coming and going periodically.
  • IgG4-Related Disease: The hallmark is often chronic, firm swelling of the major salivary glands (especially the submandibular glands under the jaw) or tear glands [3][5]. While the swelling in IgG4-RD can fluctuate in size, it usually presents as a persistent mass that rarely resolves completely without treatment [6][7]. While patients with IgG4-RD can experience dryness, the physical swelling is usually the primary feature, historically referred to as Mikulicz disease [3][5].

Systemic Symptoms: Beyond the Glands

It is important to remember that both IgG4-RD and Sjögren’s are systemic diseases—meaning they can affect the entire body, not just the head and neck. However, they tend to attack different organs:

  • Sjögren’s Syndrome frequently causes joint pain, profound fatigue, and can involve the lungs or nervous system [4].
  • IgG4-RD frequently involves the pancreas (causing autoimmune pancreatitis), the bile ducts, kidneys, and the retroperitoneum (the area behind the abdomen) [8][9].

Blood Test Differences

Blood tests provide strong clues for doctors trying to distinguish between the two conditions.

Test Primary Sjögren’s Syndrome IgG4-Related Disease
Anti-SSA (Ro) / Anti-SSB (La) Usually Positive. These autoantibodies are classic markers for Sjögren’s [4][10]. Usually Negative [11][10].
Serum IgG4 Levels Normal levels [12]. Often Elevated. However, up to 30-40% of patients may have normal levels [13][14].
ANA & Rheumatoid Factor (RF) Frequently positive [4]. Typically negative [4][15].

Note: High IgG4 in the blood alone is not enough to diagnose IgG4-RD, as it can be elevated in other inflammatory conditions [13]. Furthermore, looking at the ratio of IgG4 to total IgG can sometimes be more helpful than just the IgG4 number alone [16].

Biopsy Differences

Because blood tests can sometimes be inconclusive, a tissue biopsy is considered the “gold standard” to confirm which disease is attacking the glands [17]. When a pathologist looks at the tissue under a microscope, they look for distinct patterns:

  • In Sjögren’s Syndrome: The tissue shows focal lymphocytic sialadenitis [4][18]. This means lymphocytes (a type of white blood cell) gather in clusters specifically around the saliva ducts [19]. It lacks the specific scarring patterns of IgG4-RD [20].
  • In IgG4-Related Disease: The tissue shows a dense invasion of plasma cells that specifically produce the IgG4 antibody [21][22]. It also features two very specific patterns rarely seen in Sjögren’s:
    • Storiform Fibrosis: A swirling, cartwheel-like pattern of scar tissue [6][20].
    • Obliterative Phlebitis: Inflammation that blocks the veins inside the gland [6][22].

The Rare “Overlap” Syndrome: Can You Have Both?

It is incredibly rare, but there are documented cases where patients present with an overlap of both conditions simultaneously [15]. In these instances, a patient might have a biopsy that proves they have the deep scarring of IgG4-RD, but their bloodwork also shows classic Sjögren’s autoantibodies (anti-SSA/SSB) [15].

If you are diagnosed with an overlap syndrome, your care team will have to design a tailored approach. The primary goal is usually to quickly control the aggressive tissue swelling and potential organ damage from IgG4-RD (often with steroids or targeted therapies) while also managing the long-term systemic symptoms and dryness associated with Sjögren’s [23][24].

Why Differentiating Matters for Treatment

Getting an accurate diagnosis between these two mimics is crucial because their treatment pathways diverge significantly [4][2].

  • IgG4-RD typically responds rapidly to glucocorticoids (steroids like prednisone) [7]. The glandular swelling often shrinks dramatically when steroids are introduced [25]. For maintenance or steroid-resistant cases, targeted therapies like rituximab (a medication that depletes specific immune B-cells) are highly effective [26][27].
  • Sjögren’s Syndrome glandular swelling does not usually have the same dramatic, rapid response to steroid therapy. Treatment focuses more heavily on symptom management (like moisture replacement), local therapies, and long-term immunomodulators (medications that help regulate the immune system) [2]. Using high-dose steroids for standard Sjögren’s might expose a patient to unnecessary side effects without the intended benefits [2].

Frequently Asked Questions

Is IgG4-related disease the same as Sjögren's syndrome?
No, they are different immune system disorders. While both conditions target the salivary and tear glands, Sjögren's gradually damages the tissue and impairs moisture production. IgG4-Related Disease aggressively inflames the glands, causing them to enlarge without always stopping moisture production.
How do the symptoms of IgG4-Related Disease differ from Sjögren's?
Sjögren's syndrome is primarily characterized by severe dry mouth and severe dry eyes. In contrast, IgG4-Related Disease usually presents as a persistent, firm swelling of the major salivary or tear glands, though some dryness can occasionally occur.
Can a blood test tell the difference between Sjögren's and IgG4-Related Disease?
Yes, blood tests provide strong clues. Patients with Sjögren's typically test positive for Anti-SSA or Anti-SSB autoantibodies. Those with IgG4-Related Disease usually test negative for these antibodies but often have elevated levels of IgG4 in their blood.
Why is a tissue biopsy needed to distinguish IgG4-Related Disease from Sjögren's?
Because blood tests can sometimes be inconclusive, a tissue biopsy is considered the gold standard for an accurate diagnosis. A pathologist will look for distinct cellular patterns, such as storiform fibrosis, which is a specific type of scar tissue found in IgG4-Related Disease but not in Sjögren's.
Do IgG4-Related Disease and Sjögren's require different treatments?
Yes, an accurate diagnosis is critical because the treatments are entirely different. IgG4-Related Disease typically responds rapidly to steroids like prednisone or targeted therapies. Sjögren's treatment focuses heavily on moisture replacement and long-term immunomodulators.

Questions for Your Doctor

  • • Based on my bloodwork and symptoms, do I need a tissue biopsy to confidently rule out IgG4-Related Disease?
  • • Should we check my ratio of IgG4 to total IgG, rather than just looking at my absolute IgG4 levels?
  • • If my pathology report shows IgG4-positive plasma cells, does it also show the 'storiform fibrosis' or 'obliterative phlebitis' required to confirm an IgG4-RD diagnosis?
  • • How would a confirmed diagnosis of IgG4-RD change my current treatment plan compared to standard Sjögren's?
  • • If my autoantibodies for Sjögren's are positive but my biopsy points to IgG4-RD, how do we manage a potential overlap between the two?

Questions for You

  • • Is my glandular swelling constant and firm, or does it frequently come and go?
  • • Aside from dry eyes and dry mouth, am I experiencing any unusual symptoms in my abdomen, back, joints, or other areas of my body?
  • • Have I ever been treated with a course of steroids (like prednisone) for my swelling, and if so, did it shrink rapidly in response?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Tear levels of IL-7, IL-1α, and IL-1β may differentiate between IgG4-related disease and Sjögren's syndrome.

    Martín-Nares E, Hernández-Molina G, Lima G, et al.

    Clinical rheumatology 2023; (42(4)):1101-1105 doi:10.1007/s10067-023-06501-2.

    PMID: 36627528
  2. 2

    Immunoglobulin G4-related disease and idiopathic multicentric Castleman's disease: confusable immune-mediated disorders.

    Sasaki T, Akiyama M, Kaneko Y, Takeuchi T

    Rheumatology (Oxford, England) 2022; (61(2)):490-501 doi:10.1093/rheumatology/keab634.

    PMID: 34363463
  3. 3

    IgG4-related Dacryoadenitis and Sialadenitis with Palatal Gland Swelling.

    Yoshida M, Baba A, Hashimoto K, et al.

    The Bulletin of Tokyo Dental College 2021; (62(1)):41-47 doi:10.2209/tdcpublication.2020-0002.

    PMID: 33583876
  4. 4

    Immune Profile Differences between IgG4-Related Diseases and Primary Sjögren's Syndrome.

    Qin Y, Shang L, Wang Y, et al.

    Journal of inflammation research 2025; (18()):911-923 doi:10.2147/JIR.S471266.

    PMID: 39871956
  5. 5

    IgG4-related disease.

    Kubo K, Yamamoto K

    International journal of rheumatic diseases 2016; (19(8)):747-62 doi:10.1111/1756-185X.12586.

    PMID: 26259069
  6. 6

    Clinical profile of IgG4-related disease in Japan based on the rare disease data registry.

    Yamamoto M, Kanda M, Mizushima I, et al.

    Immunological medicine 2025; (48(3)):192-202 doi:10.1080/25785826.2024.2430812.

    PMID: 39607031
  7. 7

    A multicenter phase II prospective clinical trial of glucocorticoid for patients with untreated IgG4-related disease.

    Masaki Y, Matsui S, Saeki T, et al.

    Modern rheumatology 2017; (27(5)):849-854 doi:10.1080/14397595.2016.1259602.

    PMID: 27846767
  8. 8

    Clinical characteristics and multimodal imaging insights of coronary involvement in immunoglobulin G4-related disease.

    Wang G, Du Y, Bai Y, et al.

    Frontiers in immunology 2025; (16()):1685508 doi:10.3389/fimmu.2025.1685508.

    PMID: 41425560
  9. 9

    Thoracic manifestations of IgG4-related disease.

    Muller R, Ebbo M, Habert P, et al.

    Respirology (Carlton, Vic.) 2023; (28(2)):120-131 doi:10.1111/resp.14422.

    PMID: 36437514
  10. 10

    Clinical features and mechanistic insights regarding IgG4-related dacryoadenitis and sialoadenitis: a review.

    Maehara T, Pillai S, Stone JH, Nakamura S

    International journal of oral and maxillofacial surgery 2019; (48(7)):908-916 doi:10.1016/j.ijom.2019.01.006.

    PMID: 30686634
  11. 11

    IgG4-related disease: an update on pathology and diagnostic criteria with a focus on salivary gland manifestations.

    Czarnywojtek A, Agaimy A, Pietrończyk K, et al.

    Virchows Archiv : an international journal of pathology 2024; (484(3)):381-399 doi:10.1007/s00428-024-03757-0.

    PMID: 38316669
  12. 12

    Elevated Serum IgG4 Levels in Diagnosis, Treatment Response, Organ Involvement, and Relapse in a Prospective IgG4-Related Disease UK Cohort.

    Culver EL, Sadler R, Simpson D, et al.

    The American journal of gastroenterology 2016; (111(5)):733-43 doi:10.1038/ajg.2016.40.

    PMID: 27091321
  13. 13

    IgG4-related periaortitis presenting as left flank pain.

    Sharrack S, Paddock M

    Radiology case reports 2024; (19(2)):572-575 doi:10.1016/j.radcr.2023.11.003.

    PMID: 38074428
  14. 14

    IgG4-RD-Associated Mikulicz Syndrome Without Classic Systemic Involvement-A Case Report.

    Mendoza-Vargas LÁ, Sevilla-Fuentes S, Bautista-Becerril B, et al.

    Journal of clinical medicine 2025; (14(3)) doi:10.3390/jcm14030958.

    PMID: 39941629
  15. 15

    IgG4-related retroperitoneal fibrosis overlapping with primary biliary cirrhosis and primary Sjögren's syndrome: A case report.

    Huang X, Lu B, Li M, et al.

    Medicine 2018; (97(26)):e11303 doi:10.1097/MD.0000000000011303.

    PMID: 29953016
  16. 16

    Characterization and Comparison of Patient Subgroups Suspicious for IgG4-Related Disease and Malignant Lymphoma in Patients Followed-up for Sjögren's Syndrome.

    Szántó A, Szabó K, Nagy G, et al.

    Pathology oncology research : POR 2016; (22(3)):579-85 doi:10.1007/s12253-016-0041-1.

    PMID: 26786867
  17. 17

    [Application of ultrasonography scoring system in the assessment of IgG4-related sialadenitis].

    Ning XR, Wang ZQ, Zhang SS, et al.

    Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences 2019; (51(6)):1032-1035.

    PMID: 31848499
  18. 18

    Impact of Screening for Salivary Gland by Ultrasonography.

    Onda K, Fukuhara T, Matsuda E, et al.

    Yonago acta medica 2020; (63(1)):42-46 doi:10.33160/yam.2020.02.006.

    PMID: 32158332
  19. 19

    Mikulicz's Disease With Immune Thrombocytopenia: A New Immunoglobulin G4-Mediated Disorder and Literature Review.

    Li S, Deng C, Chen J, Li F

    Archives of rheumatology 2019; (34(3)):343-347 doi:10.5606/ArchRheumatol.2019.7070.

    PMID: 31598602
  20. 20

    Imaging of Sjögren Syndrome and Immunoglobulin G4-Related Disease of the Salivary Glands.

    Fujita A

    Neuroimaging clinics of North America 2018; (28(2)):183-197 doi:10.1016/j.nic.2018.01.003.

    PMID: 29622113
  21. 21

    Clinicopathological Pearls and Diagnostic Pitfalls in IgG4-Related Disease: Challenging Case Series and Literature Review.

    Sina S, Bonisoli GL, Vitale S, et al.

    Diagnostics (Basel, Switzerland) 2025; (15(18)) doi:10.3390/diagnostics15182299.

    PMID: 41008670
  22. 22

    Diagnostic Approach to the Complexity of IgG4-Related Disease.

    Stone JH, Brito-Zerón P, Bosch X, Ramos-Casals M

    Mayo Clinic proceedings 2015; (90(7)):927-39.

    PMID: 26141331
  23. 23

    The Management of IgG4-Related Disease in Children: A Systematic Review.

    Sapountzi E, Kotanidou EP, Tsinopoulou VR, et al.

    Children (Basel, Switzerland) 2025; (12(2)) doi:10.3390/children12020213.

    PMID: 40003315
  24. 24

    [Immunoglobulin G4 disease with pancreatic affectation: the mimicker of malignancy].

    Rodríguez-Arellano KP, Muñoz-Hernández MA, Camacho-Rodríguez MA

    Revista medica del Instituto Mexicano del Seguro Social 2024; (62(3)):1-6.

    PMID: 39530858
  25. 25

    IgG4-related disease: a clinical perspective.

    Maritati F, Peyronel F, Vaglio A

    Rheumatology (Oxford, England) 2020; (59(Suppl 3)):iii123-iii131 doi:10.1093/rheumatology/kez667.

    PMID: 32348524
  26. 26

    Inebilizumab for Treatment of IgG4-Related Disease.

    Stone JH, Khosroshahi A, Zhang W, et al.

    The New England journal of medicine 2025; (392(12)):1168-1177 doi:10.1056/NEJMoa2409712.

    PMID: 39541094
  27. 27

    Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients.

    Ebbo M, Grados A, Samson M, et al.

    PloS one 2017; (12(9)):e0183844 doi:10.1371/journal.pone.0183844.

    PMID: 28915275

This page compares IgG4-Related Disease and Sjögren's syndrome for educational purposes only. Always consult your rheumatologist or healthcare provider for an accurate diagnosis and treatment plan.

Stay up to date

Get notified when new research about Primary Sjögren's Syndrome is published.

No spam. Unsubscribe anytime.